Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Kristin Verbeke, Katholieke Universiteit Leuven
ClinicalTrials.gov Identifier:
NCT01666717
First received: August 14, 2012
Last updated: August 16, 2012
Last verified: August 2012
  Purpose

The purpose of the study is to evaluate fecal metabolites profiles of Inflammatory Bowel Disease(IBD) patients versus healthy controls (HC).


Condition
Inflammatory Bowel Diseases

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling

Resource links provided by NLM:


Further study details as provided by Katholieke Universiteit Leuven:

Biospecimen Retention:   Samples With DNA

Fecal samples


Enrollment: 204
Study Start Date: August 2008
Study Completion Date: May 2012
Groups/Cohorts
Healthy controls (HC)
HC
Inflammatory Bowel Disease (IBD) patients
Crohn's disease (CD), Ulcerative colitis (UC) and pouchitis

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Primary care clinic

Criteria

Inclusion Criteria:

  • Clinical diagnosis of IBD
  • Age >18 years

Exclusion Criteria:

  • Use of antibiotics in the preceding month
  • Intake of pre- or probiotics
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01666717

Locations
Belgium
KULeuven-UZLeuven
Leuven, Vlaams-Brabant, Belgium, 3000
Sponsors and Collaborators
Katholieke Universiteit Leuven
  More Information

No publications provided

Responsible Party: Kristin Verbeke, Professor K. Verbeke, Katholieke Universiteit Leuven
ClinicalTrials.gov Identifier: NCT01666717     History of Changes
Other Study ID Numbers: ML4355_VOC
Study First Received: August 14, 2012
Last Updated: August 16, 2012
Health Authority: Belgium: Ethics Committee

Additional relevant MeSH terms:
Intestinal Diseases
Inflammatory Bowel Diseases
Gastrointestinal Diseases
Digestive System Diseases
Gastroenteritis

ClinicalTrials.gov processed this record on October 19, 2014